CG-806
APTO-CG-806-03
Phase 1 small_molecule terminated
Quick answer
CG-806 for Acute Myeloid Leukemia is a Phase 1 program (small_molecule) at Aptose Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptose Biosciences
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated